Aurora Cannabis ACB
NASDAQ ACB
$3.78 -0.13 (-3.45%)
At close: Aug 20, 2026 · 2:08 PM UTC

Aurora Cannabis (ACB) Net Income towards Common Stockholders (2017 - 2026)

Aurora Cannabis (ACB) posted quarterly Net Income towards Common Stockholders of $5.6 million for Q1 2026, down 63.46% year-over-year from $15.3 million in Q1 2025, and down 52.34% quarter-over-quarter from $11.7 million in Q4 2025.

Aurora Cannabis (ACB) Net Income towards Common Stockholders (2017 - 2026) Analysis & Trends

Aurora Cannabis (ACB) has reported Net Income towards Common Stockholders for 10 consecutive years, with $5.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders fell 63.46% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $802.1 million (down 35.01% YoY), while the FY2026 annual figure was -$42.7 million, down 110.48% from the prior year.
  • Net Income towards Common Stockholders retreated to $5.6 million in Q1 2026 per ACB's latest filing, from $11.7 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $410.6 million in Q2 2024 and bottomed at -$1.3 billion in Q1 2022.
  • Historically, Net Income towards Common Stockholders has averaged $39.4 million across 5 years, with a median of $354.2 million in 2023.
  • Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders sank 4195.43% — and 2025, when it jumped 1023.24%.
  • Aurora Cannabis' Net Income towards Common Stockholders stood at -$545.4 million in 2022, then soared by 169.56% to $379.4 million in 2023, then rose by 8.11% to $410.1 million in 2024, then slumped by 97.14% to $11.7 million in 2025, then slumped by 52.34% to $5.6 million in 2026.
  • Business Quant data shows ACB's Net Income towards Common Stockholders at $5.6 million in Q1 2026, $11.7 million in Q4 2025, and $386.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 42.98 Bn 39.33 Bn 2.15 Bn -576.00 Mn
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn 866.00 Mn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 710.19 Mn
5 United Therapeutics 22.15 Bn 19.48 Bn 683.80 Mn 333.00 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -118.80 Mn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn 144.40 Mn
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn 54.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Aurora Cannabis 233.45 Mn 161.14 Mn 25.75 Mn -2.26 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.58 Mn
Dec 31, 2025 11.71 Mn
Sep 30, 2025 386.51 Mn
Jun 30, 2025 398.33 Mn
Mar 31, 2025 15.27 Mn
Dec 31, 2024 410.12 Mn
Sep 30, 2024 398.17 Mn
Jun 30, 2024 410.62 Mn
Mar 31, 2024 -1.65 Mn
Dec 31, 2023 379.35 Mn
Sep 30, 2023 375.79 Mn
Jun 30, 2023 354.16 Mn
Mar 31, 2023 359.55 Mn
Dec 31, 2022 -545.38 Mn
Sep 30, 2022 -515.60 Mn
Jun 30, 2022 -488.98 Mn
Mar 31, 2022 -1.28 Bn
Dec 31, 2021 1.55 Bn
Sep 30, 2021 -12.00 Mn
Jun 30, 2021 -87.26 Mn